Trials / Completed
CompletedNCT00126399
A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 528 (planned)
- Sponsor
- CollaGenex Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and efficacy of 40 mg doxycycline controlled-release capsules administered once daily for the treatment of rosacea compared with a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | doxycycline |
Timeline
- Start date
- 2004-06-01
- Completion
- 2005-04-01
- First posted
- 2005-08-04
- Last updated
- 2005-08-19
Source: ClinicalTrials.gov record NCT00126399. Inclusion in this directory is not an endorsement.